市值: $3.273T 0.720%
體積(24小時): $115.5487B -20.290%
  • 市值: $3.273T 0.720%
  • 體積(24小時): $115.5487B -20.290%
  • 恐懼與貪婪指數:
  • 市值: $3.273T 0.720%
加密
主題
加密植物
資訊
加密術
影片
頭號新聞
加密
主題
加密植物
資訊
加密術
影片
bitcoin
bitcoin

$106554.015123 USD

1.63%

ethereum
ethereum

$2453.720517 USD

2.48%

tether
tether

$1.000504 USD

-0.01%

xrp
xrp

$2.184729 USD

2.30%

bnb
bnb

$645.072770 USD

0.97%

solana
solana

$146.042618 USD

2.39%

usd-coin
usd-coin

$0.999904 USD

0.00%

tron
tron

$0.273125 USD

0.17%

dogecoin
dogecoin

$0.166374 USD

2.51%

cardano
cardano

$0.586207 USD

1.45%

hyperliquid
hyperliquid

$38.596053 USD

4.50%

sui
sui

$2.807444 USD

1.32%

bitcoin-cash
bitcoin-cash

$473.606870 USD

3.34%

chainlink
chainlink

$13.383890 USD

3.88%

unus-sed-leo
unus-sed-leo

$9.032885 USD

-1.05%

加密貨幣新聞文章

葡萄牙的疫苗接種成功:保護兒童健康

2025/06/25 22:02

葡萄牙在兒童中保持高疫苗接種率,關鍵疾病的疫苗接種率超過95%,並展示了有效的公共衛生策略。

葡萄牙的疫苗接種成功:保護兒童健康

Portugal's Vaccination Success: Protecting Children's Health

葡萄牙的疫苗接種成功:保護兒童健康

Portugal is setting a high bar when it comes to keeping its kids healthy. With vaccination coverage rates consistently hitting or exceeding 95% for children up to six years old, the country is demonstrating a real commitment to public health. Let's dive into the details.

葡萄牙在保持孩子健康方面正在設置高標準。隨著疫苗接種率始終達到或超過六歲的兒童的95%,該國表現出對公共衛生的真正承諾。讓我們研究細節。

Impressive Coverage Rates

令人印象深刻的覆蓋率

The 2024 annual report from the Directorate-General for Health (DGS) paints a reassuring picture. Not only are the overall vaccination rates stellar, but specific areas show remarkable progress. For instance, a whopping 86% of babies born between August 2024 and March 2025 were vaccinated against the Respiratory Syncytial Virus (RSV) during the initial immunization campaign. This impressive figure has significantly reduced hospitalizations for infants under six months.

衛生總局(DGS)2024年的年度報告令人放心。總體疫苗接種率不僅出色,而且特定領域的進展顯著。例如,在2024年8月至2025年3月之間出生的嬰兒中有86%的嬰兒在最初的免疫運動期間接種了呼吸道合胞病毒(RSV)的疫苗接種。這一令人印象深刻的數字大大減少了六個月以下嬰兒的住院治療。

Measles, Mumps, and Rubella (MMR) on the Rise

麻疹,腮腺炎和風疹(MMR)上升

Portugal is also making strides in MMR vaccination. Coverage for the first and second doses has increased between 2023 and 2024, reaching 99% in two-year-olds and 96% in six-year-olds. These numbers reflect a sustained effort to protect children from these highly contagious diseases.

葡萄牙也在MMR疫苗接種方面取得了長足進步。在2023年至2024年之間,第一劑和第二劑的覆蓋範圍增加了,兩歲的孩子的覆蓋量達到99%,六歲的孩子達到了96%。這些數字反映了保護兒童免受這些高度傳染性疾病的持續努力。

HPV Vaccination: Closing the Gender Gap

HPV疫苗接種:縮小性別差距

Vaccination against HPV (human papillomavirus) is another success story. Coverage in girls remains high, surpassing the 90% target. Even better, the trend of increasing vaccination rates in boys is continuing, with coverage in 15-year-old boys also exceeding 90%. This is a big step towards achieving comprehensive protection against HPV-related illnesses.

針對HPV(人乳頭瘤病毒)的疫苗接種是另一個成功的故事。女孩的覆蓋範圍仍然很高,超過了90%的目標。更好的是,男孩的疫苗接種率提高的趨勢仍在繼續,15歲男孩的覆蓋範圍也超過90%。這是朝著全面保護與HPV相關疾病的全面保護的重要一步。

Other Key Vaccines

其他關鍵疫苗

The combined vaccine against tetanus, diphtheria, pertussis, and polio (DTPaVIP) achieved a coverage rate of 93% in six-year-olds. For the N. meningitidis serogroup B (MenB) vaccine, 97% of two-year-olds received the complete three-dose schedule. These figures highlight Portugal's dedication to protecting children from a wide range of preventable diseases.

六歲的疫苗對破傷風,白喉,百日咳和小兒麻痺症(DTPAVIP)的疫苗合併為六歲的覆蓋率為93%。對於N.腦膜炎血清群B(MENB)疫苗,兩歲的孩子中有97%接受了完整的三劑時間表。這些數字強調了葡萄牙致力於保護兒童免受多種可預防疾病的侵害。

Vaccination During Pregnancy

懷孕期間的疫苗接種

Vaccination against whooping cough during pregnancy is also a priority, with approximately 80.4% of eligible pregnant women receiving the Tdpa vaccine in 2024. This strategy helps protect newborns during their first few months of life, before they can be fully vaccinated themselves.

懷孕期間針對百日咳的疫苗接種也是一個優先事項,2024年,約有80.4%的符合條件的孕婦接受TDPA疫苗。該策略有助於在他們的頭幾個月生命中保護新生兒,然後才能完全接種疫苗。

Addressing Adverse Reactions

解決不良反應

While the overall picture is positive, it's important to acknowledge that adverse reactions to vaccines can occur. In 2024, there were 370 reported cases of suspected adverse reactions, which translates to about 12.8 cases per 100,000 vaccines administered. The DGS emphasizes that reporting a suspected adverse reaction doesn't automatically imply a causal relationship and that each case undergoes a thorough technical assessment.

儘管整體情況是積極的,但必須承認可能會對疫苗產生不利反應。在2024年,有370例可疑的不良反應病例,轉化為每10萬疫苗約12.8例。 DGS強調,報告可疑的不良反應並不意味著因果關係,並且每種情況都會進行徹底的技術評估。

Municipal-Level Data for Targeted Action

針對目標行動的市政級別數據

For the first time, the 2024 report includes vaccination results broken down by municipality. This level of detail allows health professionals and other stakeholders to identify geographic areas where vaccination rates may be lower and to develop targeted interventions.

2024年的報告首次包括市政當局分解的疫苗接種結果。這種詳細信息使衛生專業人員和其他利益相關者能夠確定疫苗接種率可能較低並製定有針對性干預措施的地理區域。

Seasonal Vaccination Campaigns

季節性疫苗接種運動

Portugal's commitment to vaccination extends beyond routine childhood immunizations. The autumn-winter 2024-2025 seasonal vaccination campaign saw almost 4 million vaccines administered in SNS units and community pharmacies. A high-dose flu vaccine was introduced for those 85 and over, achieving high vaccination coverage.

葡萄牙對疫苗接種的承諾超出了常規的兒童免疫接種。秋冬2024-2025季節性疫苗接種運動中,SNS單元和社區藥房施用了近400萬次疫苗。引入了85歲及以上的高劑量流感疫苗,可實現高疫苗接種覆蓋率。

Final Thoughts

最後的想法

Portugal's proactive approach to vaccination is clearly paying off, safeguarding the health of its youngest citizens. By maintaining high coverage rates and continually refining its strategies, the country is setting an example for others to follow. It's all about keeping those little ones healthy and thriving!

葡萄牙的積極疫苗接種方法顯然正在獲得回報,從而保護了其最年輕的公民的健康。通過保持較高的覆蓋率並不斷完善其策略,該國為其他人樹立了一個榜樣。一切都是為了使這些小孩子保持健康和繁榮!

免責聲明:info@kdj.com

所提供的資訊並非交易建議。 kDJ.com對任何基於本文提供的資訊進行的投資不承擔任何責任。加密貨幣波動性較大,建議您充分研究後謹慎投資!

如果您認為本網站使用的內容侵犯了您的版權,請立即聯絡我們(info@kdj.com),我們將及時刪除。

2025年06月26日 其他文章發表於